MDT ($119.29) is trading below its intrinsic value of $338.49, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
MDT is poor value based on its earnings relative to its share price (45.36x), compared to the US market average (32.7x)
Valuation
MDT is good value based on its earnings relative to its share price (45.36x), compared to the US Medical Devices industry average (55.95x)
Valuation
1 of 13
MDT News
Valuation
MDT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
45.36x
Industry
55.95x
Market
32.7x
MDT is poor value based on its earnings relative to its share price (45.36x), compared to the US market average (32.7x)
Valuation
MDT is good value based on its earnings relative to its share price (45.36x), compared to the US Medical Devices industry average (55.95x)
Valuation
MDT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.2x
Industry
8.39x
Market
60.2x
MDT is good value based on its book value relative to its share price (3.2x), compared to the US market average (60.2x)
Valuation
MDT is good value based on its book value relative to its share price (3.2x), compared to the US Medical Devices industry average (8.39x)
Valuation
MDT price to earnings growth (PEG)
For valuing profitable companies with growth potential
MDT is poor value relative to its rate of earnings growth, measured by PEG ratio (1.25x)
Valuation
MDT's financial health
Profit margin
Revenue
$7.6B
Net Income
$489.0M
Profit Margin
6.4%
MDT's Earnings (EBIT) of $3.85B are insufficient to safely cover interest payments on company debt ($30.01B)
Financials
MDT's profit margin has decreased (-2.4%) in the last year from (15.1%) to (12.7%)
Financials
Assets to liabilities
Assets
$95.9B
Liabilities
$45.6B
Debt to equity
0.6
MDT's short-term assets ($26.04B) exceed its short-term liabilities ($12.07B)
Financials
MDT's long-term liabilities ($33.50B) exceed its short-term assets ($26.04B)
Financials
MDT's debt relative to shareholder equity (0.91) has decreased or remained constant compared to 5 years ago (1.01)
Financials
MDT's debt to equity ratio (0.91) is considered high
Financials
Cash flow
Operating
$1.9B
Investing
-$2.0B
Financing
$32.0M
MDT's operating cash flow ($6.00B) may not be sufficient to safely service the company's debt ($30.01B)
Financials
Medtronic Stock FAQ
What is Medtronic's quote symbol?
(NYSE: MDT) Medtronic trades on the NYSE under the ticker symbol MDT. Medtronic stock quotes can also be displayed as NYSE: MDT.
How much is Medtronic's stock price per share?
(NYSE: MDT) Medtronic stock price per share is $119.29 today (as of Jan 20, 2021).
What is the 52 week high and low for Medtronic (NYSE: MDT)?
(NYSE: MDT) Medtronic's 52-week high was $121.41, and its 52-week low was $72.13. It is currently -1.75% from its 52-week high and 65.38% from its 52-week low.
What is Medtronic's Market Cap?
(NYSE: MDT) Medtronic's market cap is $160.35B, as of Jan 22, 2021.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Medtronic's market cap is calculated by multiplying MDT's current stock price of $119.29 by MDT's total outstanding shares of 1,344,215,261.
How much is Medtronic stock worth today?
(NYSE: MDT) Medtronic currently has 1,344,215,261 outstanding shares. With Medtronic stock trading at $119.29 per share, the total value of Medtronic stock (market capitalization) is $160.35B.
Medtronic stock was originally listed at a price of $26.25 in Dec 31, 1997. If you had invested in Medtronic stock at $26.25, your return over the last 23 years would have been 354.44%, for an annualized return of 6.8%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.